SCHEMBL7350937

SCHEMBL7350937

COc1cc(C)c2nc[nH]c2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.51
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
PARP1 P09874 1/20 0.39
BRD4 O60885 1/20 0.38
QPCT Q16769 2/20 0.38
DRD1 P21728 1/20 0.37
ADRA2A P08913 1/20 0.36
ADRA2C P18825 1/20 0.36
ADRA1D P25100 1/20 0.36
ADRA1A P35348 1/20 0.36
ADRA1B P35368 1/20 0.36
ACACB O00763 1/20 0.36
PNP P00491 1/20 0.36
ALDH1A1 P00352 3/20 0.36
QTRT1 Q9BXR0 1/20 0.36
PRNP P04156 2/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23123699 0.81 MMP12 (0.51) MMP12MEN1KMT2ABRD4QPCT
SCHEMBL3859120 0.76 PARP1 (0.56) MEN1KMT2APARP1BRD4PNP
SCHEMBL22443321 0.75 MMP12 (0.45) MMP12MEN1KMT2APARP1QPCT
SCHEMBL22443320 0.74 NR4A2 (0.44) MMP12KMT2APARP1BRD4QPCT
SCHEMBL154615 0.73 MEN1 (0.44) MMP12MEN1KMT2APARP1BRD4
SCHEMBL7922229 0.73 MEN1 (0.44) MEN1KMT2APARP1BRD4PNP
SCHEMBL12113051 0.73 MEN1 (0.44) MMP12MEN1KMT2APARP1BRD4
SCHEMBL1285346 0.73 MEN1 (0.44) MEN1KMT2APARP1BRD4QPCT
SCHEMBL13898339 0.73 MEN1 (0.44) MEN1KMT2APARP1BRD4PNP
SCHEMBL29804903 0.73 MEN1 (0.44) MMP12MEN1KMT2APARP1BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436240-A Schizophrenia, Parkinson's disease, depression or hypotensive agents using tricyclic amines THE UPJOHN COMPANY (US) 1995-07-25 US disclosed
EP-0480939-B1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY UPJOHN CO (US) 1995-01-25 EP disclosed
US-5273975-A Heterocyclic amines having central nervous system activity THE UPJOHN COMPANY (US) 1993-12-28 US disclosed
EP-0480939-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY. UPJOHN CO (US) 1992-04-22 EP disclosed
WO-1990015058-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY THE UPJOHN COMPANY (US) 1990-12-13 WO disclosed